Author Archives: Megan Thomas

#Cancer research #Genetics / genomics #Public health

Qatar Genome Programme data improves cancer screening 

A study by the Qatar Genome Research Consortium, led by Dr Lotfi Chouchane from Weill Cornell Medicine-Qatar, has reported the first landscape of cancer germline mutations – hereditary mutations – in the Qatari population.  Since then, scientists at Qatar Foundation’s (QF) Qatar Genome Programme (QGP) have teamed… Read More

#News

#Acquisition #Clinical trials #Life sciences

Beckley Psytech acquires Eleusis Therapeutics

Clinical stage company Beckley Psytech has entered into an agreement to acquire clinical-stage life science company, Eleusis Therapeutics.   Under the terms of the agreement, which has been approved by shareholders, Beckley Psytech has acquired 100% of Eleusis, receiving full developmental and commercial rights for the company’s assets… Read More

#News

#DDW Highlights podcast

DDW Highlights: 24 October 2022

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This round-up was compiled by DDW’s Diana Spencer. Read More

#Podcasts

#Collaboration #Cystic fibrosis #Neuropsychiatric disorders #RNA #Therapeutics

Latest episode of the DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available for download. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This round-up was compiled by DDW’s Diana Spencer. Amid continued… Read More

#News

#cryo-microscopy #Drug discovery #Webinar

High resolution electron cryo-microscopy: From membrane proteins to diseases

Watch the webinar High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific.  The webinar demonstrates how cryo-EM is impacting high resolution structure biology from membrane proteins to diseases including Alzheimer’s disease and cancer therapeutics by showing high-resolution structures of these… Read More

Webinar date:
Brought to you by Thermo Fisher Scientific
#Webinars

Protein
#Drug discovery #ELRIG #Events #Protein Science #Proteins

Event: Protein sciences in drug discovery

The 2022 Protein Science in Drug Discovery ELRIG meeting will be held at The Babraham Research Campus, Cambridge UK from 2-3 November 2022. The meeting will host leading scientists from industry and academia and will aim to focus on the application of emerging areas of Protein Science to the challenges of… Read More

#News

#Biologics #Life sciences #Pharmaceuticals

Podcast: The changing drug discovery landscape

This is the latest episode of the free DDW podcast, “What does the changing drug discovery and development landscape mean for the future?”. It covers three articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “The… Read More

#News

Japanese flag
#Biopharmaceutical #Collaboration #Drug discovery #Healthcare #Investment #Life sciences #Market reporting #Start-ups

A review of Japan’s drug discovery landscape  

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research.   Japan continues to be one of the largest pharmaceutical markets in the world,… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Market Reports #Trends & Analysis

#AI #Deep learning #Drug discovery #Investment #Machine learning

€30 million raised to advance AI enabled drug discovery pipeline 

Aqemia has raised €30 million in a Series A funding round to further support its mission to massively scale drug discovery through a first-in-class technological platform combining quantum-inspired physics and machine learning.  The financing was led by Eurazeo and Bpifrance through its Large Venture fund, with the… Read More

#Business & Investment #News

#DNA #Gene therapy #Plasmid DNA #RNA

Yapan Bio expands to a new process development facility in India 

Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India, which has enhanced its ability to support end-to-end development and manufacturing of RNA, DNA and gene therapy products starting from plasmids.   The expansion includes three upstream suites (including Bio-Safety Level-2… Read More

#News

#Biotechnology #Clinical trial #Liver disease

Clinical study first step towards treating respiratory syncytial virus 

Enanta Pharmaceuticals, a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has dosed the first subject in its Phase I clinical trial of EDP-323, a novel, oral L-protein inhibitor in development for the treatment of respiratory syncytial virus (RSV).  Context … Read More

#News

#Collaboration #Cystic fibrosis #Neuropsychiatric disorders #RNA #Therapeutics

New episode of the DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available for download. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This round-up was compiled by DDW’s Diana Spencer and reflects… Read More

#News

#DDW Highlights podcast

DDW Highlights: 17 October 2022

The latest episode of the DDW Highlights podcast is now available for download. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This round-up was compiled by DDW’s Diana Spencer and reflects the… Read More

#Podcasts

#Automated liquid handling #Liquid handling #Podcast

Podcast: Make liquid handling automation work for you

The newest addition to the free DDW podcast is the In Conversation With series, where DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.   In this first episode, Jessica Grossman, Chief Executive Officer at IgGenix,… Read More

#News

#In Conversation Series

Make liquid handling automation work for you

The newest addition to the free DDW podcast is the In Conversation With series, where DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.   In this first episode, Jessica Grossman, Chief Executive Officer at IgGenix,… Read More

#Podcasts